Cargando…
ID2 Inhibits Bladder Cancer Progression and Metastasis via PI3K/AKT Signaling Pathway
Background: Inhibitors of DNA-binding (ID) proteins are important regulators of cell proliferation and differentiation. The aim of this study was to evaluated the role of ID proteins in bladder cancer (BCa) and related molecular mechanisms. Methods: The TCGA database was analyzed for the expression...
Autores principales: | Mao, Weipu, Wang, Keyi, Sun, Si, Wu, Jianping, Chen, Ming, Geng, Jiang, Luo, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570141/ https://www.ncbi.nlm.nih.gov/pubmed/34746132 http://dx.doi.org/10.3389/fcell.2021.738364 |
Ejemplares similares
-
SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer
por: Xiao, Zhao-Ming, et al.
Publicado: (2021) -
PPA1 Promotes Breast Cancer Proliferation and Metastasis Through PI3K/AKT/GSK3β Signaling Pathway
por: Guo, Chunlei, et al.
Publicado: (2021) -
LTBP2 inhibits prostate cancer progression and metastasis via the PI3K/AKT signaling pathway
por: Zhang, Xiaowen, et al.
Publicado: (2022) -
TMEA, a Polyphenol in Sanguisorba officinalis, Promotes Thrombocytopoiesis by Upregulating PI3K/Akt Signaling
por: Li, Hong, et al.
Publicado: (2021) -
Major Vault Protein (MVP) Associated With BRAF
(V600E) Mutation Is an Immune Microenvironment-Related Biomarker Promoting the Progression of Papillary Thyroid Cancer via MAPK/ERK and PI3K/AKT Pathways
por: Dong, Xubin, et al.
Publicado: (2022)